OCRA’s important message urging genetic testing and consideration of prophylactic action to reduce risk of ovarian cancer has received a significant boost from various media outlets, including Yahoo! Finance and AP News. OCRA is grateful for the opportunity to reach more people with this potentially life-saving information. Read the full press release below. NEW YORK, Sept. … Continued
Special Registration for National Conference Ends Thursday, August 31st OCRA’s Ovarian Cancer National Conference returns virtually on November 1st – 3rd with important updates on research, care, and resources from top experts in the field. Topics will include new treatment developments, symptom management, caregiver concerns, and more, with interactive sessions and opportunities to connect. Regular $75 registration begins … Continued
Jill McGill, professional golfer and champion of the 2022 U.S. Senior Women’s Open, spoke to reporters at this year’s tournament about her personal connection to the ovarian cancer cause. “When you have people that close to you, it really makes you want to make a difference, not only in their lives, but in the future … Continued
A recent article from Stat News reports that as the United States continues to face a concerning shortage of vital chemotherapy drugs, ovarian cancer patients are among the hardest hit. According to Stat News, nearly 93% of U.S. cancer centers are reporting shortages of carboplatin, which is the most common first-line treatment for ovarian cancer. … Continued
In a profile with Westfair Business Journal, OCRA’s President & CEO Audra Moran speaks about her background, the direction of ovarian cancer research and prevention, and how OCRA’s programs are moving the needle forward. Read the full article, “Unlocking the secrets of ovarian cancer,” written by Georgette Gouveia and published on August 4, 2023.
September is the official month for Ovarian Cancer Awareness. Ovarian Cancer Awareness Month is our time to spread the word about risk and prevention, rally for more scientific research, and make progress toward a cure. Read on for ways you can be an ambassador for Ovarian Cancer Awareness Month! Here’s how you can make a … Continued
OCRA-Funded Study Targets Immunotherapy OCRA grantees and their Roswell Park Comprehensive Cancer Center colleagues published results from an exciting study detailing a new approach to adoptive T-cell therapy that may help improve immunotherapy options for ovarian cancer patients. Learn more about the findings from the research team, which included Dr. Bob McGray, OCRA grantee, and Dr. Kunle Odunsi, … Continued
Jill McGill, reigning champion of the U.S. Senior Women’s Open, continued to champion the ovarian cancer cause at last week’s U.S. Women’s Open at Pebble Beach, handing out special ball-markers featuring her signature on one side, and a QR code leading to OCRA’s website on the other. McGill’s campaign to make a difference is in … Continued
In a new article published in Everyday Health, experts spoke about the disparities Black Americans face when diagnosed with ovarian cancer, exploring reasons why these disparities may exist, and offering recommendations for Black individuals who are diagnosed with ovarian, fallopian tube, or primary peritoneal cancer. In particular, Black Americans should be aware of the importance … Continued
Update to Clinical Guidelines: Special Circumstance Chemotherapy Approvals Last month, we reported news of an ongoing shortage of chemotherapy drugs essential to ovarian cancer treatment. Though the shortage continues, patients affected now have more options. In early June, the National Comprehensive Care Network’s (NCCN) Clinical Practice Guidelines were updated to approve oxaliplatin-based regimens like docetaxel / oxaliplatin … Continued
Summer is officially here! Strengthen your connection to community this season with special support offerings, interactive roundtables and summer-themed sessions for those impacted by ovarian and other gynecologic cancers. And no need to leave the comfort of your climate-controlled home to attend — all meetings will be held online. “This summer, we’re offering more choices … Continued
What to Know About the Chemotherapy Drug Shortage As many are aware, the U.S. is currently experiencing a matter of great concern: an ongoing shortage of chemotherapy drugs that are essential in the treatment of ovarian cancer. The availability of these medications is of critical importance to patients and their families, and we understand the anxiety … Continued
Get email updates about research news, action alerts, and ways to join the fight.
